Transmission rates of hepatitis C virus by different batches of a contaminated anti-D immunoglobulin preparation

Vox Sanguinis

Volumn 76, Issue 3, 1999, Pages 138-143

  Lawlor, E ^a,b   Power, J ^a   Garson, J A ^c   Yap, P L ^d   Davidson, F ^d   Columb, G ^a   Smith, D ^d   Pomeroy, L ^a   O'Riordan, J ^a   Simmonds, P ^d   Tedder, R S ^c  

^a IRISH BLOOD TRANSFUSION SERVICE   (Ireland)

^b TRINITY COLLEGE DUBLIN   (Ireland)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^d Pelican House ^*

Author keywords

[No Author keywords available]

Indexed keywords

RHESUS D ANTIBODY; VIRUS RNA;

ARTICLE; ENZYME IMMUNOASSAY; FEMALE; GENOME; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOBLOTTING; INFECTION RATE; IRELAND; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCREENING; VIRUS INACTIVATION; VIRUS TRANSMISSION;

EID: 0032910634     PISSN: 00429007     EISSN: None     Source Type: Journal    
DOI: 10.1159/000031038     Document Type: Article

References (21)

1. Yap PL: Viral Safety of IVIG; in Lee ML, Strand V (eds): Intravenous Immunoglobulins in Clinical Practice. New York, Dekker. 1997, pp 67-105.
2. Yap PL, McOmish F, Webster ADB, Hammarstrom L, Smith CIE, Bjorkander J, Ochs HD, Fischer S, Quinti I, Simmonds P: Hepatitis C virus transmission by intravenous immunoglobulin. J Hepatol 1994;21:455-460.
3. Report of the Expert Group on the Blood Transfusion Service Board Published by the Irish Government Stationery Office, Dublin 1995 (pn 1538).
4. Power JP, Lawlor E, Davidson F, Yap PL, Kenny-Walsh E, Whelton MJ, Walsh TJ: Hepatitis C viraemia in recipients of Irish intravenous anti D immunoglobulin. Lancet 1994;334: 116-117.
5. Power JP, Lawlor E, Davidson F, Holmes EC, Yap PL, Simmonds P: Molecular epidemiology of an outbreak of infection with hepatitis C virus in recipients of anti-D immunoglobulin. Lancet 1995;345:1211-1213.
6. Chan S-W, McOmish F. Holmes EC, Dom B, Peutherer JF, Follet EAC, Yap PL, Simmonds PN: Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants. J Gen Virol 1992;73:1131-1141.
7. Hoppe HH, Krebs H-J, Wester TH, Hennig W: Herstellung von Anti-Rh-gammaglobulin zur Immunisierungsprophylaxe. Münch Med Wochensch 1967;109:1749-1752.
8. Hoppe HH, Mester T, Hennig W, Krebs HJ: Prevention of Rh-immunization. Modified production of IgG anti-Rh for intravenous application by ion exchange chromatography (IEC). Vox Sang 1973;25:308-316.
9. Cunningham CJ: Production of human immunoglobulin anti-D(Rho) for intravenous administration for a national Rh prophylaxis programme. Biochem Soc Trans 1980;8:178.
10. Garson JA, Preston FE, Makris M, Tuke P, Ring C, Machin S, Tedder RS: Detection by PCR of hepatitis C virus in factor VIII concentrates. Lancet 1990;335:1473.
11. Whilby K, Garson JA: Optimisation and evaluation of a quantitative chemiluminescent polymerase chain reaction assay for hepatitis C virus RNA. J Virol Methods 1995;51:75-88.
12. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidimium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
13. Saldanha J, Minor P: Collaborative study to assess the suitability of an HCV RNA reference sample for detection of an HCV RNA in plasma pools by PCR. Vox Sang 1996;70:148-151.
14. Smith DR, Pathira S, Davidson F, Lawlor E, Power J, Yap PL, Simmonds P: The origins of hepatitis C virus genotypes. J Gen Virol 1997;78:321-328.
15. Craske J, Spooner RJD, Vandervelde EM: Evidence for existence of at least two types of factor-VIII-associated non-B transfusion hepatitis. Lancet 1978;ii:1051-1052.
16. Hart H, McOmish F, Hart WG, Yap PL, Simmonds P: A comparison of PCR with an infectivity assay for HIV-I titration during virus inactivation of blood products. Transfusion 1993;33:838-841.
17. Alter HC: To C or not to C: These are the questions. Blood 1995;85:1681-1695.
18. Dittman S, Roggendorf M. Durkop J, Weise M, Lorberr B, Deinhardt F: Long-term persistence of hepatitis C virus antibodies in a single source outbreak. J Hepatol 1991;13:323-327.
19. Japson AP: Infection...by the new genetics. J Infect 1996;33:1-5.
20. Zoltan RP, Padvelskis JV: Evaluation of an ion exchange procedure for removal of hepatitis type B contamination from human gamma-globulin products. Vox Sang 1984;47: 114-121.
21. Hilfenhaus J, Groner A, Nowak T, Weimer T: Analysis of human plasma products: Polymerase chain reaction does not discriminate between live and inactivated viruses Transfusion 1997;37:935-940.